Developer docs
API playgroundTry for free, no card

Search company profiles

中国金融策略投资控股 China Finance Strategies Investment Holdings

Full company profile

uuid0044ac4

Namestring
中国金融策略投资控股 China Finance Strategies Investment Holdings
Legal namestring
中国金融策略投资控股集团
Websiteurl
cfsih.com
Company typeenum
Private
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHong Kong, Hong Kong SAR China
HQ citystring
Hong Kong
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
equity investment services, investment banking advisory, asset management services, private equity investing, capital markets advisory
Industry3 codes
PRIMARYFSAEAGAE
Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYFSAEALAM
Debt Capital Raising Intermediation (Private Debt/Mezzanine/Bonds)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Investment Banking and Asset Management
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Equity Investment Returns
TypeSubscription Recurring
Description

CFS invests its own funds and managed funds into high-growth enterprises, generating returns through equity appreciation, exits via IPO or M&A, and dividend income.

cfsih.com
2Investment Banking & Advisory Fees
TypeProfessional Services
Description

Provides financing, listing, M&A and restructuring advisory services to corporate clients, earning fees for transaction facilitation.

cfsih.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

China Finance Strategies Investment Holdings (CFS) provides equity investment using its own funds and managed funds, alongside investment banking advisory services covering corporate financing, IPO sponsorship, private placements, bond issuance, M&A, and restructuring. The firm targets high-growth enterprises with a particular focus on life sciences, biotech, advanced manufacturing, clean energy, and financial services, offering long-term capital and capital markets execution support across Hong Kong, mainland China, and international exchanges.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • USD 100 billion+ cumulative investment volume led by team leadership
+4 more records
Product overview1 text field

China Financial Strategy Investment Holdings Group is a financial investment and consulting services company, not a traditional technology product company. The company offers equity investment services using its own funds and managed funds, investment banking advisory services covering corporate financing, IPO, M&A and restructuring, and strategic consulting. The company's investment portfolio includes life sciences and biotech companies (BioMetas, ChemPartner, Viva Biotech, XtalPi, 3D Medicines, VivaVision Bio, MindRank, Drug Farm), as well as companies in consumer goods, manufacturing, energy, and financial sectors (Wison Group, Topsec, GCL Silicon Industry).

Product and service1 record
1Equity Investment Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

CFS acts as an investor and ecosystem supporter for Baijun Bio (BioMetas), a preclinical CRO providing one-stop drug discovery solutions. CFS participated in funding and strategic development of the company, which recently signed a strategic integration agreement with Hugangzk to build a full preclinical CRO service chain.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hong Kong-based PE firm founded by former CICC banker Fang Fenglei, managing large-cap investments across China with sovereign and institutional LP base. Comparable to CFS as a HK-domiciled PE firm with deep cross-border execution and senior banker pedigree.

TypeBroad incumbent
Description

One of China's largest alternative investment managers with deep PE/VC franchise spanning consumer, healthcare, industrials, and TMT. Comparable to CFS as a HK/China PE firm with healthcare investment focus and cross-border deal execution, but operating at materially larger scale.

TypeBroad incumbent
Description

China's premier investment bank with full-service ECM, M&A, and asset management capabilities plus CICC Capital PE platform. Comparable to CFS as a Chinese IB with PE arm and cross-border execution, though operating at vastly larger scale with state-affiliated LP backing.

TypeBroad incumbent
Description

Hong Kong-headquartered PE firm founded by ex-CICC executives, focused on growth and control investments across consumer, healthcare, and TMT in China. Comparable to CFS as a HK-based PE firm with healthcare sector focus and senior banker pedigree, though with larger fund scale.

TypeBroad incumbent
Description

Hong Kong-headquartered alternative investment management firm with PE, real estate, and credit funds operating globally. Comparable to CFS as a HK-based Chinese-affiliated investment firm with cross-border deal execution capability, though at significantly larger AUM scale.

TypeDirect peer
Description

Hong Kong-listed boutique investment bank with PE/VC arm founded by Bao Fan, providing IB advisory and equity investment services to growth-stage Chinese companies with strong life sciences and tech exposure. Most structurally comparable to CFS given hybrid model, similar target client base, and HK-domiciled private deal focus.

TypeEmerging player
Description

China-focused alternative investment firm with strong healthcare and biotech investment thesis, deploying capital into growth and pre-IPO stage Chinese companies. Comparable to CFS in life sciences investment focus and Chinese biotech deal sourcing, though operating as a more recently established player.

TypeBroad incumbent
Description

Hong Kong-based investment banking arm of Bank of China providing ECM, advisory, and asset management services globally. Comparable to CFS in IB advisory focus and cross-border execution; notably, CFS founders came from BoCom International (a sibling institution) with similar mandate profile.

TypeBroad incumbent
Description

Hong Kong-based PE firm founded by ex-TPG China team, focused on large-cap control and growth investments across China and Southeast Asia. Comparable to CFS as a HK-domiciled Chinese-affiliated PE firm with significant cross-border deal flow, though at much larger scale.

TypeBroad incumbent
Description

Hong Kong-headquartered investment banking arm of China Merchants Bank offering ECM, DCM, M&A advisory, and asset management. Comparable to CFS as a HK-based Chinese-affiliated IB with regulatory licensing and cross-border transaction capability, though operating as part of a larger commercial banking franchise.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

中国金融策略投资控股 China Finance Strategies Investment Holdings

Investment Banking and Asset Managementcfsih.com

中国金融策略投资控股 China Finance Strategies Investment Holdings firmographics

Firmographics
Name
中国金融策略投资控股 China Finance Strategies Investment Holdings
Legal name
中国金融策略投资控股集团
Website
https://cfsih.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

中国金融策略投资控股 China Finance Strategies Investment Holdings industry classification

Industry
Product category
Investment Banking and Asset Management
NAICS
Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSAEAGAE
Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYFSAEALAM
Debt Capital Raising Intermediation (Private Debt/Mezzanine/Bonds)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation

Keywords

  • Equity investment services
  • Investment banking advisory
  • Asset management services
  • Private equity investing
  • Capital markets advisory

Where 中国金融策略投资控股 China Finance Strategies Investment Holdings is headquartered

Location

Headquarters

HQ city
Hong Kong
HQ country
Hong Kong SAR China
HQ region
Asia

Offices4 records

Markets served

中国金融策略投资控股 China Finance Strategies Investment Holdings business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Equity Investment Returns: CFS invests its own funds and managed funds into high-growth enterprises, generating returns through equity appreciation, exits via IPO or M&A, and dividend income.
  2. Investment Banking & Advisory Fees: Provides financing, listing, M&A and restructuring advisory services to corporate clients, earning fees for transaction facilitation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

中国金融策略投资控股 China Finance Strategies Investment Holdings product offering

Product offering

Core offering

China Finance Strategies Investment Holdings (CFS) provides equity investment using its own funds and managed funds, alongside investment banking advisory services covering corporate financing, IPO sponsorship, private placements, bond issuance, M&A, and restructuring. The firm targets high-growth enterprises with a particular focus on life sciences, biotech, advanced manufacturing, clean energy, and financial services, offering long-term capital and capital markets execution support across Hong Kong, mainland China, and international exchanges.

Product overview

China Financial Strategy Investment Holdings Group is a financial investment and consulting services company, not a traditional technology product company. The company offers equity investment services using its own funds and managed funds, investment banking advisory services covering corporate financing, IPO, M&A and restructuring, and strategic consulting. The company's investment portfolio includes life sciences and biotech companies (BioMetas, ChemPartner, Viva Biotech, XtalPi, 3D Medicines, VivaVision Bio, MindRank, Drug Farm), as well as companies in consumer goods, manufacturing, energy, and financial sectors (Wison Group, Topsec, GCL Silicon Industry).

Differentiator

Problem solved

Functional benefit

Products and services

  • Equity Investment Services

Quantifiable outcome

  • USD 100 billion+ cumulative investment volume led by team leadership
  • +4 more outcomes

Companies that use 中国金融策略投资控股 China Finance Strategies Investment Holdings

Customer profile

Named customers17 records

Segments2 records

Ideal customer profiles2 records

中国金融策略投资控股 China Finance Strategies Investment Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

中国金融策略投资控股 China Finance Strategies Investment Holdings partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Baijun Bio (佰君生物)coreStrategic or Co-development Partner · 13 April 2026CFS acts as an investor and ecosystem supporter for Baijun Bio (BioMetas), a preclinical CRO providing one-stop drug discovery solutions. CFS participated in funding and strategic development of the company, which recently signed a strategic integration agreement with Hugangzk to build a full preclinical CRO service chain.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

中国金融策略投资控股 China Finance Strategies Investment Holdings competitors and assessment

Company assessment

Broad incumbents

  • Hopu Investments: Hong Kong-based PE firm founded by former CICC banker Fang Fenglei, managing large-cap investments across China with sovereign and institutional LP base. Comparable to CFS as a HK-domiciled PE firm with deep cross-border execution and senior banker pedigree.
  • CDH Investments: One of China's largest alternative investment managers with deep PE/VC franchise spanning consumer, healthcare, industrials, and TMT. Comparable to CFS as a HK/China PE firm with healthcare investment focus and cross-border deal execution, but operating at materially larger scale.
  • China International Capital Corporation (CICC): China's premier investment bank with full-service ECM, M&A, and asset management capabilities plus CICC Capital PE platform. Comparable to CFS as a Chinese IB with PE arm and cross-border execution, though operating at vastly larger scale with state-affiliated LP backing.
  • FountainVest Partners: Hong Kong-headquartered PE firm founded by ex-CICC executives, focused on growth and control investments across consumer, healthcare, and TMT in China. Comparable to CFS as a HK-based PE firm with healthcare sector focus and senior banker pedigree, though with larger fund scale.
  • CITIC Capital: Hong Kong-headquartered alternative investment management firm with PE, real estate, and credit funds operating globally. Comparable to CFS as a HK-based Chinese-affiliated investment firm with cross-border deal execution capability, though at significantly larger AUM scale.
  • BOC International: Hong Kong-based investment banking arm of Bank of China providing ECM, advisory, and asset management services globally. Comparable to CFS in IB advisory focus and cross-border execution; notably, CFS founders came from BoCom International (a sibling institution) with similar mandate profile.
  • Boyu Capital: Hong Kong-based PE firm founded by ex-TPG China team, focused on large-cap control and growth investments across China and Southeast Asia. Comparable to CFS as a HK-domiciled Chinese-affiliated PE firm with significant cross-border deal flow, though at much larger scale.
  • CMB International: Hong Kong-headquartered investment banking arm of China Merchants Bank offering ECM, DCM, M&A advisory, and asset management. Comparable to CFS as a HK-based Chinese-affiliated IB with regulatory licensing and cross-border transaction capability, though operating as part of a larger commercial banking franchise.

Direct peers

  • China Renaissance Holdings: Hong Kong-listed boutique investment bank with PE/VC arm founded by Bao Fan, providing IB advisory and equity investment services to growth-stage Chinese companies with strong life sciences and tech exposure. Most structurally comparable to CFS given hybrid model, similar target client base, and HK-domiciled private deal focus.

Emerging players

  • Loyal Valley Capital: China-focused alternative investment firm with strong healthcare and biotech investment thesis, deploying capital into growth and pre-IPO stage Chinese companies. Comparable to CFS in life sciences investment focus and Chinese biotech deal sourcing, though operating as a more recently established player.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

中国金融策略投资控股 China Finance Strategies Investment Holdings social profiles

Digital presence

中国金融策略投资控股 China Finance Strategies Investment Holdings compliance and trust

Trust signal

Compliance3 records

中国金融策略投资控股 China Finance Strategies Investment Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

中国金融策略投资控股 China Finance Strategies Investment Holdings leadership team

Management profile

Number of profiles

Profiles8 records

中国金融策略投资控股 China Finance Strategies Investment Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

中国金融策略投资控股 China Finance Strategies Investment Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

中国金融策略投资控股 China Finance Strategies Investment Holdings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 中国金融策略投资控股 China Finance Strategies Investment Holdings

What does 中国金融策略投资控股 China Finance Strategies Investment Holdings do?

China Finance Strategies Investment Holdings (CFS) provides equity investment using its own funds and managed funds, alongside investment banking advisory services covering corporate financing, IPO sponsorship, private placements, bond issuance, M&A, and restructuring. The firm targets high-growth enterprises with a particular focus on life sciences, biotech, advanced manufacturing, clean energy, and financial services, offering long-term capital and capital markets execution support across Hong Kong, mainland China, and international exchanges.

Is 中国金融策略投资控股 China Finance Strategies Investment Holdings a public or private company?

中国金融策略投资控股 China Finance Strategies Investment Holdings is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was 中国金融策略投资控股 China Finance Strategies Investment Holdings founded?

中国金融策略投资控股 China Finance Strategies Investment Holdings was founded in 2005. It employs 1 to 10 people.

Where is 中国金融策略投资控股 China Finance Strategies Investment Holdings based?

中国金融策略投资控股 China Finance Strategies Investment Holdings is headquartered in Hong Kong, Hong Kong SAR China, in the Asia region.

How does 中国金融策略投资控股 China Finance Strategies Investment Holdings make money?

Two revenue lines are on record. Equity Investment Returns are the primary driver. The others are investment Banking & Advisory Fees.

Who are 中国金融策略投资控股 China Finance Strategies Investment Holdings's main competitors?

Broad incumbents on record are Hopu Investments, CDH Investments, China International Capital Corporation (CICC), FountainVest Partners, CITIC Capital, BOC International, Boyu Capital and CMB International. China Renaissance Holdings is listed as a direct peer. Loyal Valley Capital is listed as an emerging player.

Does 中国金融策略投资控股 China Finance Strategies Investment Holdings have an API?

No public API is recorded for 中国金融策略投资控股 China Finance Strategies Investment Holdings.

What industry is 中国金融策略投资控股 China Finance Strategies Investment Holdings in?

中国金融策略投资控股 China Finance Strategies Investment Holdings's product category is Investment Banking and Asset Management. Its primary akta.pro industry code is FSAEAGAE, Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps), with a secondary code of BPAHADAB, Corporate Finance & Capital Advisory. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales